Skip to main content
OpenTrials

Clinical trial condition

Glioblastoma, IDH-wildtype

Explore clinical trials studying Glioblastoma, IDH-wildtype. Study availability and eligibility vary by location and protocol.

35 public trials 25 recruiting studies
Refine in advanced search Browse all conditions

Glioblastoma, IDH-wildtype trial results

Recruiting

Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma

NCT06419946

Conditions
Astrocytoma, Glioblastoma, Glioblastoma, IDH-wildtype, +9 more
Locations
  • University Hospital Graz Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
  • Kepler University Hospital Linz, Austria
  • University Hospital St. Pölten Sankt Pölten, Austria
View all 20 locations
View Trial Details
Recruiting

Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma

NCT05879367

Conditions
Astrocytoma, Astrocytoma, IDH-Mutant, GBM, +12 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Henry Ford Hospital Detroit, Michigan, United States
  • Columbia University Medical Center - Herbert Irving Pavilion New York, United States
  • Duke University Durham, North Carolina, United States
View Trial Details
Recruiting

The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)

NCT06283927

Conditions
Astrocytoma, Astrocytoma of Brain, Astrocytoma, Malignant, +14 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Hospital Leuven Leuven, Belgium
  • University Hospital Heidelberg Heidelberg, Germany
View Trial Details
Recruiting

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

NCT06273176

Conditions
Astrocytoma, Astrocytoma, Malignant, Brain Diseases, +25 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • University Hospital Leuven Leuven, Belgium
  • Universitätsklinikum Heidelberg Heidelberg, Germany
View Trial Details

Related conditions